Format

Send to

Choose Destination
Life Sci Alliance. 2019 Feb 4;2(1). pii: e201800284. doi: 10.26508/lsa.201800284. Print 2019 Feb.

Somatic recombination underlies frequent revertant mosaicism in loricrin keratoderma.

Author information

1
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
2
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan nomura@huhp.hokudai.ac.jp.
3
Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
4
Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.

Abstract

Revertant mosaicism is a phenomenon in which pathogenic mutations are rescued by somatic events, representing a form of natural gene therapy. Here, we report on the first evidence for revertant mosaicism in loricrin keratoderma (LK), an autosomal dominant form of ichthyosis caused by mutations in LOR on 1q21.3. We identified two unrelated LK families exhibiting dozens of previously unreported white spots, which increased in both number and size with age. Biopsies of these spots revealed that they had normal histology and that causal LOR mutations were lost. Notably, dense single nucleotide polymorphism mapping identified independent copy-neutral loss-of-heterozygosity events on chromosome 1q extending from regions centromeric to LOR to the telomere in all investigated spots, suggesting that somatic recombination represents a common reversion mechanism in LK. Furthermore, we demonstrated that reversion of LOR mutations confers a growth advantage to cells in vitro, but the clinically limited size of revertant spots suggests the existence of mechanisms constraining revertant clone expansion. Nevertheless, the identification of revertant mosaicism in LK might pave the way for revertant therapy for this intractable disease.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center